Screening for MRSA

Por Wilcox, Mark H
Publicado em 2008

Reply to ‘Clostridium difficile period of increased incidence in hospitals’

Por Wilcox, Mark H
Publicado no J Infect Prev (2015)

Hospital infection past and present

Por Wilcox, Mark H
Publicado no Lancet (2003)

Acute obstructive hydrocephalus complicating bacterial meningitis : In meningitis, one antibiotic is better than than two

Por Settle, Christopher, Wilcox, Mark H
Publicado em 1999

Diagnosing genitourinary chlamydial infection : Vaginal swabs alone may not be sufficient

Por Wilcox, Mark H, Subramanian, Dhinagar
Publicado em 2001

Antibiotic therapy and Clostridium difficile infection – primum non nocere – first do no harm

Por Crowther, Grace S, Wilcox, Mark H
Publicado no Infect Drug Resist (2015)

A Review of Mixed Strain Clostridium difficile Colonization and Infection

Por Dayananda, Pete, Wilcox, Mark H.
Publicado no Front Microbiol (2019)

Ultrasensitive Detection of Clostridium difficile Toxins Reveals Suboptimal Accuracy of Toxin Gene Cycle Thresholds for Toxin Predictions

Por Sandlund, Johanna, Wilcox, Mark H.
Publicado no J Clin Microbiol (2019)

Reply to Tenover et al., “Guidelines Support the Value of Stand-Alone Nucleic Acid Amplification Tests for Clostridioides (Clostridium) difficile Infection”

Por Sandlund, Johanna, Wilcox, Mark H.
Publicado no J Clin Microbiol (2019)

Pulsed-Field Gel Electrophoresis Can Yield DNA Fingerprints of Degradation-Susceptible Clostridium difficile Strains

Por Fawley, Warren N., Wilcox, Mark H.
Publicado em 2002

Data are not widely applicable

Por Wilcox, Mark H, Sandoe, Jonathan A
Publicado em 2007

An Enhanced DNA Fingerprinting Service To Investigate Potential Clostridium difficile Infection Case Clusters Sharing the Same PCR Ribotype

Por Fawley, Warren N., Wilcox, Mark H.
Publicado em 2011

Antibodies for Treatment of Clostridium difficile Infection

Por Humphreys, David P., Wilcox, Mark H.
Publicado em 2014

Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection

Por Baines, Simon D., Wilcox, Mark H.
Publicado no Antibiotics (Basel) (2015)

1344. Ridinilazole (RDZ) for Clostridium difficile Infection (CDI): Impact of Diagnostic Method on Outcomes From a Phase 2 Clinical Trial

Por Vickers, Richard, Chowdhury, Sumita, Wilcox, Mark
Publicado no Open Forum Infect Dis (2018)

Molecular diagnostic techniques

Por Fawley, Warren N, Wilcox, Mark H
Publicado no Medicine (Abingdon) (2005)

Ultrasensitive Clostridioides difficile Toxin Testing for Higher Diagnostic Accuracy

Por Sandlund, Johanna, Davies, Kerrie, Wilcox, Mark H.
Publicado no J Clin Microbiol (2020)

Tolevamer Is Not Efficacious in the Neutralization of Cytotoxin in a Human Gut Model of Clostridium difficile Infection

Por Baines, Simon D., Freeman, Jane, Wilcox, Mark H.
Publicado em 2009

Comparison of Nine Commercially Available Clostridium difficile Toxin Detection Assays, a Real-Time PCR Assay for C. difficile tcdB, and a Glutamate Dehydrogenase Detection Assay t...

Por Eastwood, Kerrie, Else, Patrick, Charlett, André, Wilcox, Mark
Publicado em 2009

Models for the study of Clostridium difficile infection

Por Best, Emma L., Freeman, Jane, Wilcox, Mark H.
Publicado em 2012